An example of pharmaceutical care for a patient with osteoarthritis

Abstract

Osteoarthritis (osteoarthrosis) is a major source of pain, disability, and socioeconomic cost worldwide. The epidemiology of the disorder is complex and multifaceted, with genetic, biological, and biomechanical components. [1,2]

Acute joint pain associated with arthritis affects adults of all ages, both sexes, and all races and ethnicities. Most of what we know about acute joint pain is for adults. [2,3]

Arthritis is a chronic disease of the articular apparatus, during which there is primary progressive dystrophy (degeneration) and destruction of bone-cartilage, proliferation of underlying bone tissue, structural changes of the articular surface of the bone before its complete destruction, the appearance of osteophytes, secondary inflammation of the synovial membrane, which causes joint deformation.[4,5,6]

  The purpose of the study was to determine the role of the clinical pharmacist in patients with osteoarthritis, as he will analyze the possible options for drug interactions, the features of the pharmacokinetics and pharmacodynamics of drugs, the possibilities of detecting side effects, and will give the correct, adequate advice to the patient in order to reduce the unfortunate consequences caused by the simultaneous appointment of drugs.

   The task of the research was to study the history of the patient with osteoarthritis and to analyze the prescription together with the attending physician, in order to eliminate possible adverse interactions of the drugs.

   The subject of the study was the history, anamnesis and purpose of the patient with osteoarthritis. We considered the official treatment protocol.